Ginsenoside Rg3 , Analysis of standards,> 98% , 14197-60-5
Synonym(s):
(3β,12β)-12,20-Dihydroxydammar-24-en-3-yl 2-O-β-D -glucopyranosyl-β-D -glucopyranoside;20(S)-Ginsenoside-Rg3;Rg3
Pack Size | Price | Stock | Quantity |
20MG | RMB220.80 | In Stock |
|
50mg | RMB543.20 | In Stock |
|
100mg | RMB959.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 315-318°C |
Boiling point: | 885.0±65.0 °C(Predicted) |
Density | 1.30 |
storage temp. | 2-8°C |
solubility | DMSO: ≥5mg/mL |
pka | 12.85±0.70(Predicted) |
form | powder |
color | white to beige |
optical activity | [α]/D +10 to +20°, c = 1 in methanol |
InChIKey | RWXIFXNRCLMQCD-JBVRGBGGSA-N |
Description and Uses
Ginsenosides are pharmacologically active natural constituents of ginseng and other plants of the genus Panax. Structurally, they are steroid glycosides derived from the triterpene squalene. Ginsenoside Rg3 is a panaxadiol found in white and red P. ginseng. This ginsenoside has diverse in vitro and in vivo effects, including anti-
Ginsenoside Rg3 shows a synergistic antitumor effect with cisplatin in cisplatin-resistant bladder tumor cell lines and is considered to be an anti-tumor agent.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P301+P312+P330 |
Hazard Codes | Xn |
Risk Statements | 22 |
WGK Germany | 3 |
RTECS | LY9537300 |
HS Code | 29389090 |
Toxicity | mouse,LD50,intraperitoneal,1250mg/kg (1250mg/kg),Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 343, 1975. |